Patents by Inventor Omer Malachi

Omer Malachi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7884226
    Abstract: Provided are processes for the purification of a pure rosuvastatin intermediate by thin film evaporation and chemical method, and conversion of the intermediate to rosuvastatin or salts thereof.
    Type: Grant
    Filed: July 14, 2008
    Date of Patent: February 8, 2011
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Tamar Nidam, Omer Malachi, Irena Veinberg, Valerie Niddam-Hildesheim, Vinod Kumar Kansal, Harish Ranjan, Appu Ekambaram Ponnuswamy, Sunil Rokad, Surat Kiran, Debashish Das
  • Publication number: 20100121072
    Abstract: Provided are candesartan cilexetil forms and methods of their preparation. Also provided are pharmaceutical compositions prepared by combining at least one pharmaceutically-acceptable excipient with at least one candesartan cilexetil form of the invention.
    Type: Application
    Filed: January 13, 2010
    Publication date: May 13, 2010
    Inventors: Marina Yu Etinger, Boris Fedotev, Tamas Koltai, Ziv Kurgan, Omer Malachi
  • Patent number: 7692023
    Abstract: Provided are candesartan cilexetil forms and methods of their preparation. Also provided are pharmaceutical compositions prepared by combining at least one pharmaceutically-acceptable execipient with at least one candesartan cilexetil form of the invention.
    Type: Grant
    Filed: February 11, 2005
    Date of Patent: April 6, 2010
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Marina Yu Etinger, Boris Fedotev, Tamas Koltai, Ziv Kurgan, Omer Malachi
  • Publication number: 20090099383
    Abstract: Provided are processes for the purification of a pure rosuvastatin intermediate by thin film evaporation and chemical method, and conversion of the intermediate to rosuvastatin or salts thereof.
    Type: Application
    Filed: July 14, 2008
    Publication date: April 16, 2009
    Inventors: Tamar Nidam, Omer Malachi, Irena Veinberg, Valerie Niddam-Hildesheim, Vinod Kumar Kansal, Harish Ranjan, Appu Ekambaram Ponnuswamy, Sunil Rokad, Surat Kiran, Debashish Das
  • Publication number: 20070161796
    Abstract: The invention encompasses amorphous montelukast sodium having less than about 50 ppm heptane or less than about 100 ppm hexane, less than about 150 ppm toluene, and less than about 2500 ppm C1-C5 alcohols, as well as processes for its preparation.
    Type: Application
    Filed: November 16, 2006
    Publication date: July 12, 2007
    Inventors: Ilan Kor-Sade, Amir Gold, Claude Singer, Ziv Dee-Noor, Omer Malachi
  • Publication number: 20060270723
    Abstract: The present invention provides a process for the preparation of amorphous valsartan.
    Type: Application
    Filed: January 11, 2006
    Publication date: November 30, 2006
    Inventors: Tamas Koltai, Omer Malachi, Nisim Sasson, Amir Gold
  • Publication number: 20060223845
    Abstract: Provided is clopidogrel base suitable for pharmaceutical formulation, and processes for its preparation.
    Type: Application
    Filed: February 24, 2006
    Publication date: October 5, 2006
    Inventors: Eran Turgeman, Omer Malachi
  • Publication number: 20060194858
    Abstract: A process for preparing candesartan cilexetil comprising heating a solution of trityl candesartan cilexetil in a water immiscible solvent in the presence of at least one C1-C4 alcohol and a first portion of water; combining the solution with a second portion of water to obtain a two-phase system; and recovering candesartan cilexetil.
    Type: Application
    Filed: January 17, 2006
    Publication date: August 31, 2006
    Inventors: Omer Malachi, Ziv Kurgan
  • Publication number: 20050250828
    Abstract: Provided are candesartan cilexetil forms and methods of their preparation. Also provided are pharmaceutical compositions prepared by combining at least one pharmaceutically-acceptable excipient with at least one candesartan cilexetil form of the invention.
    Type: Application
    Filed: February 11, 2005
    Publication date: November 10, 2005
    Inventors: Marina Etinger, Boris Fedotev, Tamas Koltai, Ziv Kurgan, Omer Malachi